Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

[The core of the Apple Heart Study].

Engdahl J, Svennberg E.

Lakartidningen. 2020 Feb 17;117. pii: FYY6. Swedish.

PMID:
32068877
2.

Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation-Compliance and ease of use in an ambulatory elderly population.

Fredriksson T, Kemp Gudmundsdottir K, Frykman V, Friberg L, Al-Khalili F, Engdahl J, Svennberg E.

Clin Cardiol. 2020 Jan 9. doi: 10.1002/clc.23323. [Epub ahead of print]

3.

Screening for Atrial Fibrillation to Initiate Stroke-Protective Therapy.

Svennberg E, Engdahl J, Rosenqvist M.

Am Fam Physician. 2020 Jan 1;101(1):6-7. No abstract available.

PMID:
31894945
4.

Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study.

Kemp Gudmundsdottir K, Fredriksson T, Svennberg E, Al-Khalili F, Friberg L, Frykman V, Hijazi Z, Rosenqvist M, Engdahl J.

Europace. 2020 Jan 1;22(1):24-32. doi: 10.1093/europace/euz255.

5.

Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study.

Atterman A, Friberg L, Asplund K, Engdahl J.

Europace. 2020 Jan 1;22(1):58-65. doi: 10.1093/europace/euz306.

PMID:
31750897
6.

Are persistent organic pollutants important in the etiology of feline hyperthyroidism? A review.

Jones B, Engdahl JN, Weiss J.

Acta Vet Scand. 2019 Oct 3;61(1):45. doi: 10.1186/s13028-019-0478-9. Review.

7.

Role of baseline 12‑lead ECG in predicting syncope caused by arrhythmia in patients investigated using an implantable loop recorder.

Sandgren E, Rorsman C, Edvardsson N, Engdahl J.

Int J Cardiol Heart Vasc. 2019 Jun 27;24:100386. doi: 10.1016/j.ijcha.2019.100386. eCollection 2019 Sep.

8.

Comprehensive analyses of geographical inequalities in cardiovascular disease incidence and survival: A possible aid to rationalize prevention strategies.

Strömberg U, Holmén A, Engdahl J.

Eur J Prev Cardiol. 2019 Nov;26(17):1824-1827. doi: 10.1177/2047487319856940. Epub 2019 Jun 10. No abstract available.

PMID:
31180760
9.

Electrocardiography Screening for Atrial Fibrillation.

Engdahl J, Svennberg E, Rosenqvist M.

JAMA. 2018 Dec 25;320(24):2598. doi: 10.1001/jama.2018.17764. No abstract available.

PMID:
30575869
10.

Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.

Sandgren E, Rorsman C, Edvardsson N, Engdahl J.

PLoS One. 2018 Sep 13;13(9):e0203661. doi: 10.1371/journal.pone.0203661. eCollection 2018.

11.

Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial Fibrillation.

Fredriksson T, Frykman V, Friberg L, Al-Khalili F, Engdahl J, Svennberg E.

Am J Cardiol. 2018 Oct 1;122(7):1179-1184. doi: 10.1016/j.amjcard.2018.06.030. Epub 2018 Jul 4.

PMID:
30064858
12.

Is atrial fibrillation a risk factor for in-hospital cardiac arrest?: a Swedish retrospective cohort study.

Ryden A, Engdahl J, Claesson A, Nordberg P, Ringh M, Hollenberg J, Djärv T.

BMJ Open. 2018 Jun 30;8(6):e022092. doi: 10.1136/bmjopen-2018-022092.

13.

A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.

Engdahl J, Holmén A, Rosenqvist M, Strömberg U.

Europace. 2018 Nov 1;20(FI_3):f306-f311. doi: 10.1093/europace/euy045.

PMID:
29688312
14.

Factors of importance to 30-day survival after in-hospital cardiac arrest in Sweden - A population-based register study of more than 18,000 cases.

Hessulf F, Karlsson T, Lundgren P, Aune S, Strömsöe A, Södersved Källestedt ML, Djärv T, Herlitz J, Engdahl J.

Int J Cardiol. 2018 Mar 15;255:237-242. doi: 10.1016/j.ijcard.2017.12.068. Epub 2017 Dec 24.

PMID:
29289346
15.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.

Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.

PMID:
28483832
16.

Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis.

Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Levin LÅ.

Europace. 2017 Oct 1;19(10):1650-1656. doi: 10.1093/europace/eux002.

PMID:
28340009
17.

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.

Svennberg E, Henriksson P, Engdahl J, Hijazi Z, Al-Khalili F, Friberg L, Frykman V.

Heart. 2017 Aug;103(16):1271-1277. doi: 10.1136/heartjnl-2016-310236. Epub 2017 Mar 2.

PMID:
28255099
18.

Defibrillation before EMS arrival in western Sweden.

Claesson A, Herlitz J, Svensson L, Ottosson L, Bergfeldt L, Engdahl J, Ericson C, Sandén P, Axelsson C, Bremer A.

Am J Emerg Med. 2017 Aug;35(8):1043-1048. doi: 10.1016/j.ajem.2017.02.030. Epub 2017 Feb 16.

PMID:
28238537
19.

Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.

Engdahl J, Svennberg E, Friberg L, Al-Khalili F, Frykman V, Kemp Gudmundsdottir K, Fredriksson T, Rosenqvist M.

Europace. 2017 Feb 1;19(2):297-302. doi: 10.1093/europace/euw319.

PMID:
28011798
20.

Why should we screen for atrial fibrillation?

Svennberg E, Engdahl J.

Heart. 2017 Jan 1;103(1):6-7. doi: 10.1136/heartjnl-2016-310305. Epub 2016 Oct 12. No abstract available.

PMID:
27733534
21.

Drug therapy in cardiac arrest: a review of the literature.

Lundin A, Djärv T, Engdahl J, Hollenberg J, Nordberg P, Ravn-Fischer A, Ringh M, Rysz S, Svensson L, Herlitz J, Lundgren P.

Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):54-75. doi: 10.1093/ehjcvp/pvv047. Epub 2015 Nov 26. Review.

PMID:
27533062
22.

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

Engdahl J, Holmén A, Svennberg E, Friberg L, Frykman-Kull V, Al-Khalili F, Rosenqvist M, Strömberg U.

Int J Cardiol. 2016 Nov 1;222:430-435. doi: 10.1016/j.ijcard.2016.07.198. Epub 2016 Jul 29.

PMID:
27505329
23.

Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack.

Olsson AS, Engdahl J.

J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2648-2652. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.010. Epub 2016 Aug 1.

PMID:
27492946
24.

Campylobacter jejuni-associated perimyocarditis: two case reports and review of the literature.

Hessulf F, Ljungberg J, Johansson PA, Lindgren M, Engdahl J.

BMC Infect Dis. 2016 Jun 14;16:289. doi: 10.1186/s12879-016-1635-7. Review.

25.

Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients.

Waldenhjort D, Sobocinski Doliwa P, Alam M, Frykman-Kull V, Engdahl J, Rosenqvist M, Persson H.

Scand Cardiovasc J. 2016 Aug;50(4):236-42. doi: 10.1080/14017431.2016.1175657. Epub 2016 May 18.

PMID:
27192631
26.

Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation.

Svennberg E, Stridh M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M.

Europace. 2017 Sep 1;19(9):1449-1453. doi: 10.1093/europace/euw286.

PMID:
28339578
27.

[Looking for atrial fibrillation--several reasons for screening].

Svennberg E, Engdahl J.

Lakartidningen. 2015 Sep 8;112. pii: DHSI. Review. Swedish.

28.

Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study.

Sandgren E, Rorsman C, Engdahl J, Edvardsson N.

Open Heart. 2015 Jul 27;2(1):e000249. doi: 10.1136/openhrt-2015-000249. eCollection 2015.

29.

Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?

Johansson AK, Juhlin T, Engdahl J, Lind S, Hagwall K, Rorsman C, Fodor E, Alenholt A, Paul Nordin A, Rosenqvist M, Frick M.

Europace. 2015 Oct;17(10):1514-7. doi: 10.1093/europace/euv123. Epub 2015 May 27.

PMID:
26017466
30.

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.

Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M.

Circulation. 2015 Jun 23;131(25):2176-84. doi: 10.1161/CIRCULATIONAHA.114.014343. Epub 2015 Apr 24.

PMID:
25910800
31.

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.

Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman-Kull V, Levin LÅ.

Europace. 2015 Jul;17(7):1023-9. doi: 10.1093/europace/euv083. Epub 2015 Apr 12.

PMID:
25868469
32.

[Uncertain if drugs do any good after cardiac arrest].

Engdahl J, Hollenberg J, Rubertsson S, Holmgren C, Rosenqvist M.

Lakartidningen. 2015 Mar 30;112. pii: CZ4R. Review. Swedish. No abstract available.

33.

[More and more defibrillators in the community--but few used].

Hollenberg J, Ringh M, Fredman D, Claesson A, Engdahl J.

Lakartidningen. 2015 Mar 31;112. pii: C7E6. Review. Swedish. No abstract available.

34.

Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation.

Engdahl J, Holmén A, Rosenqvist M, Strömberg U.

BMC Public Health. 2013 Aug 3;13:715. doi: 10.1186/1471-2458-13-715.

35.

Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention.

Engdahl J, Andersson L, Mirskaya M, Rosenqvist M.

Circulation. 2013 Feb 26;127(8):930-7. doi: 10.1161/CIRCULATIONAHA.112.126656. Epub 2013 Jan 23.

PMID:
23343564
36.

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP).

Friberg L, Engdahl J, Frykman V, Svennberg E, Levin LÅ, Rosenqvist M.

Europace. 2013 Jan;15(1):135-40. doi: 10.1093/europace/eus217. Epub 2012 Jul 11.

PMID:
22791299
37.

Outcome after out-of-hospital cardiac arrest witnessed by EMS: changes over time and factors of importance for outcome in Sweden.

Axelsson C, Claesson A, Engdahl J, Herlitz J, Hollenberg J, Lindqvist J, Rosenqvist M, Svensson L.

Resuscitation. 2012 Oct;83(10):1253-8. doi: 10.1016/j.resuscitation.2012.01.043. Epub 2012 Feb 28.

PMID:
22388092
38.

Improvement in the hospital organisation of CPR training and outcome after cardiac arrest in Sweden during a 10-year period.

Aune S, Eldh M, Engdahl J, Holmberg S, Lindqvist J, Svensson L, Oddby E, Herlitz J.

Resuscitation. 2011 Apr;82(4):431-5. doi: 10.1016/j.resuscitation.2010.11.021. Epub 2011 Jan 16.

PMID:
21242019
39.

Characteristics of cardiac arrest and resuscitation by age group: an analysis from the Swedish Cardiac Arrest Registry.

Herlitz J, Svensson L, Engdahl J, Gelberg J, Silfverstolpe J, Wisten A, Angquist KA, Holmberg S.

Am J Emerg Med. 2007 Nov;25(9):1025-31.

PMID:
18022497
40.

Characteristics and outcome in out-of-hospital cardiac arrest when patients are found in a non-shockable rhythm.

Herlitz J, Svensson L, Engdahl J, Silfverstolpe J.

Resuscitation. 2008 Jan;76(1):31-6. Epub 2007 Aug 20.

PMID:
17709164
41.

An evaluation of post-resuscitation care as a possible explanation of a difference in survival after out-of-hospital cardiac arrest.

Hollenberg J, Lindqvist J, Ringh M, Engdahl J, Bohm K, Rosenqvist M, Svensson L.

Resuscitation. 2007 Aug;74(2):242-52. Epub 2007 Mar 23.

PMID:
17363131
42.

Characteristics and outcome amongst young adults suffering from out-of-hospital cardiac arrest in whom cardiopulmonary resuscitation is attempted.

Herlitz J, Svensson L, Silfverstolpe J, Angquist KA, Wisten A, Engdahl J, Holmberg S.

J Intern Med. 2006 Nov;260(5):435-41.

43.

Association between interval between call for ambulance and return of spontaneous circulation and survival in out-of-hospital cardiac arrest.

Herlitz J, Svensson L, Engdahl J, Angquist KA, Silfverstolpe J, Holmberg S.

Resuscitation. 2006 Oct;71(1):40-6. Epub 2006 Aug 30.

PMID:
16945468
44.

Major differences in 1-month survival between hospitals in Sweden among initial survivors of out-of-hospital cardiac arrest.

Herlitz J, Engdahl J, Svensson L, Angquist KA, Silfverstolpe J, Holmberg S.

Resuscitation. 2006 Sep;70(3):404-9. Epub 2006 Jul 10.

PMID:
16828952
45.

[Rigid training support rules are unfair to both students and the society].

Engdahl J.

Lakartidningen. 2005 Dec 12-31;102(50):3925. Swedish. No abstract available.

PMID:
16425870
46.

Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style.

Langhelle A, Nolan J, Herlitz J, Castren M, Wenzel V, Soreide E, Engdahl J, Steen PA; 2003 Utstein Consensus Symposium.

Resuscitation. 2005 Sep;66(3):271-83.

PMID:
16129543
47.
48.

Factors associated with an increased chance of survival among patients suffering from an out-of-hospital cardiac arrest in a national perspective in Sweden.

Herlitz J, Engdahl J, Svensson L, Angquist KA, Young M, Holmberg S.

Am Heart J. 2005 Jan;149(1):61-6.

PMID:
15660035
49.

Changes in demographic factors and mortality after out-of-hospital cardiac arrest in Sweden.

Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S.

Coron Artery Dis. 2005 Feb;16(1):51-7.

PMID:
15654201
50.

Characteristics and outcome among children suffering from out of hospital cardiac arrest in Sweden.

Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S.

Resuscitation. 2005 Jan;64(1):37-40.

PMID:
15629553

Supplemental Content

Loading ...
Support Center